Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPHI Middle eastCPHI Middle east
Not Confirmed
Not Confirmed
10-12 December, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Not Confirmed
Not Confirmed
24 November-17 July, 2025
Health 2.0 ConferenceHealth 2.0 Conference
Not Confirmed
Not Confirmed
02-04 December, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPHI Middle eastCPHI Middle east
Industry Trade Show
Not Confirmed
10-12 December, 2024
Medlab Asia & Asia Hea...Medlab Asia & Asia Health
Industry Trade Show
Not Confirmed
24 November-17 July, 2025
Health 2.0 ConferenceHealth 2.0 Conference
Industry Trade Show
Not Confirmed
02-04 December, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
07 Nov 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almacs-singapore-facility-secures-gmp-certification/
28 Oct 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almac-pharma-services-recruitment-event/
09 Oct 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almac-chemist-recognised-as-future-leader-at-cphi-celebration-awards-2024/
01 Oct 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almac-group-announces-11m-investment-to-expand-global-analytical-services/
30 Sep 2024
// PRESS RELEASE
https://www.almacgroup.com/news/almac-pharma-services-appoints-new-vp-finance/
24 Sep 2024
// PRESS RELEASE
https://www.almacgroup.com/news/arran-chemical-company-celebrates-40-successful-years-in-business/
Details:
The agreement aims for the potential launch and commercialization of Tonmya (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets), a centrally acting, non-opioid medication, in the US.
Lead Product(s): Cyclobenzaprine
Therapeutic Area: Musculoskeletal Brand Name: Tonmya
Study Phase: Phase IIIProduct Type: Small molecule
Sponsor: Tonix Pharmaceuticals Holding Corp
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 20, 2024
Lead Product(s) : Cyclobenzaprine
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Tonix Pharmaceuticals Holding Corp
Deal Size : Undisclosed
Deal Type : Agreement
Tonix Selects Two Contract Manufacturers For Launch Of Tonmya For Fibromyalgia Management
Details : The agreement aims for the potential launch and commercialization of Tonmya (also known as TNX-102 SL, cyclobenzaprine HCl sublingual tablets), a centrally acting, non-opioid medication, in the US.
Brand Name : Tonmya
Molecule Type : Small molecule
Upfront Cash : Undisclosed
March 20, 2024
Details:
This funding supports efforts to combat the COVID-19 pandemic through the rapid process development and manufacturing of remdesivir.
Lead Product(s): Remdesivir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Veklury
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: COVID-19 Therapeutics Accelerator
Deal Size: $0.5 million Upfront Cash: Undisclosed
Deal Type: Funding November 17, 2020
Lead Product(s) : Remdesivir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : COVID-19 Therapeutics Accelerator
Deal Size : $0.5 million
Deal Type : Funding
Almac Group Works to Enable Efficient Manufacturing of Remdesivir in Response to COVID-19
Details : This funding supports efforts to combat the COVID-19 pandemic through the rapid process development and manufacturing of remdesivir.
Brand Name : Veklury
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 17, 2020